Changes at the drugs market in the Western Balkans

To improve understanding of the impact of the pandemic and associated measures on the drug market in the Western Balkans, the European Drugs Agency (EMCDDA) published ad hoc publication Illicit drug markets and supply in the Western Balkans: Impact of COVID-19.

This report provides the main results of studies conducted using the trendspotter methodology to explore the impact of the pandemic and associated measures on the drug markets and supply in the Western Balkans.

Reported here are the findings of a rapid multidisciplinary expert opinion study to review the possible impact of COVID-19 on the operation of the drug market. The current situation is extremely dynamic.

The findings of the study should be interpreted with caution as they are based substantially on expert opinions gathered from law enforcement sources between September and October 2020, when the research was conducted. In general, very limited statistical or research data is available in the Western Balkan region on drug markets during this period. Therefore, the conclusions are necessarily preliminary and will require review as more data sources become available.

To read the report, please follow this link>>>.

 

COVID-19 and drug markets

UNODC press release

Measures implemented by governments to curb the COVID-19 pandemic have led to drug trafficking routes by air being disrupted, along with drastic reduction or increased interdiction in trafficking routes over land. Some drug supply chains have been interrupted and traffickers are looking for alternative routes, including maritime routes, depending on the types of drugs smuggled. These are some of the findings from a report on drug market trends during COVID-19, launched on 7 May by the United Nations Office on Drugs and Crime (UNODC).

Synthetic drugs, such as methamphetamine tend to be trafficked across continents by air more than other types of drugs. Restrictions on air travel are, therefore, likely to have a particularly drastic effect on this illegal cargo. The bulk of cocaine is trafficked by sea and large cargos have continued to be detected in European ports during the pandemic.

So far, heroin has mostly been trafficked by land. But due to the pandemic, maritime routes seem to be increasingly used now to traffic heroin as shown by seizures of opiates in the Indian Ocean.

Trafficking in cannabis, however, may not be affected in the same way as that of heroin or cocaine, given that its production often takes place near consumer markets and traffickers are thus less reliant on long, transregional shipments of large quantities of the drug.

 

Drug consumption trends

Several countries have reported drug shortages at the retail level. This can lead to an overall decrease in consumption, but mainly of drugs mostly consumed in recreational settings.

In the case of heroin, however, a shortage in supply can lead to the consumption of harmful, domestically produced substances – heroin shortages have been reported by countries in Europe, South West Asia and North America and some countries in Europe have warned that heroin users may even switch to fentanyl and its derivatives.

An increase in the use of pharmaceutical products such as benzodiazepines has also been reported, already doubling their price in certain areas. Another harmful pattern resulting from drug shortages is the increase in injecting drug use and the sharing of injecting equipment. All of which carry the risk of spreading diseases like HIV/AIDS, hepatitis C, and COVID-19 itself. The risk of drug overdose may also increase among those injecting drugs and who are infected with COVID-19.

 

Trends in drug production

Restrictions resulting from lockdown could hinder the production of opiates with the key months of harvest in Afghanistan being March to June. Due to COVID-19 labour force might not be able or willing to travel to areas where opium poppy is grown in the country, which could affect this year’s harvest.

Cocaine production also appears to be impeded in Colombia, as producers are suffering from a shortage of gasoline. While in Bolivia, COVID-19 is limiting the ability of state authorities to control coca bush cultivation, which could lead to an increase in coca production. In Peru, however, a drop in the price of cocaine suggests a reduction in trafficking opportunities. This may discourage coca bush cultivation in the short-term, although the looming economic crisis may lead more farmers to take up coca cultivation in all the major cocaine producing countries.

A decline in international trade in the current pandemic could also lead to shortages in the supply of precursors, vital for the manufacture of heroin as well as for synthetic drugs. A limited supply in Mexico, for example seems to have disrupted the manufacture of methamphetamine and fentanyl, while in Lebanon and Syria it is affecting the production of captagon. Czechia on the other hand expects a shortage of metamphetamine for the same reasons.

In the long-run, the economic downturn caused by the COVID-19 pandemic has the potential to lead to a lasting and profound transformation of the drug markets, which can be fully understood only after more research is done. The economic difficulties caused by COVID-19 may affect people who are already in position of socioeconomic disadvantage harder than others.

The COVID-19 and drug markets Report is available online here >>>

EU Drug Markets Report 2019

Drug trafficking is a highly profitable commercial activity and remains a core business for organised crime groups across Europe today. Understanding the reality of the European drug market requires a holistic approach, following the supply chain from production and trafficking to distribution and sales.

Taking such an approach, two EU agencies – the EMCDDA and Europol – have joined forces to provide their third state-of-the-art overview of the European illicit drug market in the form of the EU Drug Markets Report 2019.

The analysis presented in this report spans numerous topics such as the links between drugs and other crimes, the licit economy and society more generally as well as the processes and players involved in the trade, from production and trafficking to distribution. Taking an evidence-based approach, the report reviews the markets for heroin, cocaine, cannabis, amphetamine, methamphetamine, MDMA and new psychoactive substances. It also provides action points to inform policy development at EU and national level. This publication is an essential reference for law enforcement professionals, policymakers, the academic community and indeed for anyone seeking up-to-date information and analysis on drug markets in Europe.

The latest data show that overall drug availability within Europe remains ‘very high’ and that consumers have access to a wide variety of high-purity and high-potency products at steady, or falling, prices. An important cross-cutting theme in the report is the environmental impact of drug production, including deforestation and the dumping of chemical waste, which can result in ecological damage, safety risks and high clean-up costs.

The report highlights the increasing importance of Europe, both as a target and drug-producing region, and shows how the violence and corruption, long seen in traditional drug-producing countries, are now increasingly evident within the EU. Among the wide-ranging consequences of the drug market presented in the analysis are its negative impacts on society (e.g. gang violence, drug-related homicide) and the strain on public institutions and governance. The drug market’s links to wider criminal activity (e.g. human trafficking, terrorism) are also explored, along with its negative repercussions on the legal economy (e.g. how money laundering associated with the drug trade undermines legitimate businesses).

To read full report, follow this link>>>

A short presentation of the main highlights from the EU Drug Markets Report 2019, targeting policy and practice is available in a separate document available here>>>